Praxis Precision (PRAX) is down -5.7%, or -$17.24 to $287.34.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRAX:
- Compelling Risk‑Reward in Praxis Precision Medicines: Breakthrough Ulixacaltamide, Platform Upside, and $340 Target Price Support Buy Rating
- Praxis Precision rises 14.1%
- Praxis Precision Medicines: Breakthrough Neurology Pipeline and Regulatory Momentum Support Upside and Buy Rating
- Praxis Precision rises 14.7%
- Breakthrough designation gives Praxis ‘notable FDA validation,’ says Jefferies